Trials / Completed
CompletedNCT00422955
Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.
A 16-week, Randomised, Double-blind, Placebo-controlled, Single-centre Study to Investigate Fluid Retention in Insulin-treated Subjects With Type 2 Diabetes Mellitus and Varying Degrees of Autonomic Neuropathy When Administered Rosiglitazone 4mg Twice Daily
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Fluid management study in patients with type 2 diabetes and autonomic neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rosiglitazone |
Timeline
- Start date
- 2003-11-01
- Primary completion
- 2005-10-01
- Completion
- 2005-10-01
- First posted
- 2007-01-17
- Last updated
- 2016-09-15
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00422955. Inclusion in this directory is not an endorsement.